Which Comes First: The Woman or Her Eggs?
By Ruha Benjamin,
Huffington Post
| 04. 17. 2013
[Quotes CGS's Marcy Darnovsky]
To Pay or Not to PayImagine two women sitting in a waiting room -- one is a store clerk, and the other is an investment banker -- preparing to donate their eggs for a particular type of stem cell research.* There are some who think that payment could coerce women, especially those who are low-income, to undergo the
invasive procedure.** Marcy Darnovsky, the executive director of the Center for Genetics and Society,
says that restricting payment can help prevent "the emergence of a market in which predominantly poor women are the ones who wind up selling their eggs."
Others insist that women are perfectly capable of weighing their options, and that egg donors should be financially rewarded for their time and trouble. UC Hastings law professor
Radhika Rao contends:
[E]veryone else involved in the production of human embryonic stem cells is entitled to compensation. The researchers who invest intellectual capital and the companies and universities that invest financial capital will surely share in any profits ... so why not those who provide the human capital in the form...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...